Metabolic Response to Food in Lung Cancer
Reason given: Poor accrual.
Key facts
- Where
- Baton Rouge, United StatesSee the site
Where in United States
- Pennington Biomedical Research CenterBaton Rouge, United StatesNo longer taking part
Trial details
- Who runs it
- Pennington Biomedical Research Center
- Trial code
- NCT05937074
- Record updated
- 17 September 2026
- Original description
This goal of this study is to describe how unintentional weight loss influences fasting and post-prandial metabolic flexibility in participants with advanced non-small cell lung cancer.Read full original descriptionShow less
This goal of this study is to describe how unintentional weight loss influences fasting and post-prandial metabolic flexibility in participants with advanced non-small cell lung cancer.
Inclusion: Age greater than or equal to 18 years; Diagnosis of non-small-cell lung cancer; Reported weight stability or loss after cancer diagnosis; Body mass index less than or equal to 35 kilograms per meter squared; Ability to provide written informed consent; Willing and able to comply with all scheduled visits, treatment plans, lab tests, and other study procedure; Allow the collection and storage of biospecimens and data for future use.
Exclusion: Prior diagnosis of diabetes mellitus (type 1 or type 2); Any medications affecting gastric motility; Any other condition that, in the investigator's opinion, would preclude participation or successful compliance with the protocol; Currently pregnant or breastfeeding; Contraindication to consuming the liquid mixed meal.